vimarsana.com

Page 3 - Ind Swift Laboratories News Today : Breaking News, Live Updates & Top Stories | Vimarsana

IndiaRF acquires Ind-Swift business for Rs 1,650 crore

IndiaRF acquires Ind-Swift business for Rs 1,650 crore
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Shantanu nalavadiIndia resurgence fundPiramal enterprisesBain capitalInd swift laboratoriesSynthimed labsImpresario entertainment

Ind-Swift Labs to sell API biz to IndiaRF for Rs 1,650 cr

Ind-Swift Labs to sell API biz to IndiaRF for Rs 1,650 cr
tribuneindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tribuneindia.com Daily Mail and Mail on Sunday newspapers.

New delhiJammu and kashmirIndia resurgence fundEuropean unionPiramal enterprisesInd swift laboratoriesResurgence fundBain capital

India s Ind-Swift Labs to sell pharma ingredients ops for $198 5 million

India s Ind-Swift Laboratories said on Wednesday it would sell its active pharmaceuticals ingredients and contract research and manufacturing services business to Synthimed Labs in a deal with.

Savio dsouzaAshish chandraInd swift labsInd swift laboratoriesSynthimed labsSaviod souza

Ind-Swift Labs approves slump sale of API business for Rs 1,650 crore

Equity value of the transaction is worth Rs 850 crore, considering an approximate debt of Rs 800 crore

Ind swift laboratoriesActive pharmaceutical ingredientsSynthimed labsBusiness transfer agreementInd swift labs

Bain-Piramal s IndiaRF seals $200-mn pharma deal in its biggest bet

India Resurgence Fund (IndiaRF), the distressed and special situations investment platform set up by India's Piramal Group and US-based Bain Capital Credit, has struck its ..

Bain piramal indiaShantanu nalavadiIndia resurgence fundIndia piramal groupResurgence fundPiramal groupBain capital creditImpresario entertainmentBain capital creditIndia resurgence fundInd swift laboratoriesAnuj suvarnaPrivate equity

vimarsana © 2020. All Rights Reserved.